Abstract
Background
The overexpression of histone deacetylases (HDACs) has been observed in many cancers and inhibition of specific HDACs has emerged as a new target for cancer therapy. We found that HDAC7 expression was selectively reduced by HDAC inhibitor apicidin in salivary mucoepidermoid carcinoma (MEC) cells. Here, we show that HDAC7 suppression has a potent anti-tumor effect in MEC cells.
Methods
HDAC7 was knocked down using HDAC7 siRNAs and cell proliferation was quantified. Cell cycle progression, apoptosis, and autophagy were measured by flow cytometry and immunoblotting.
Results
HDAC7 siRNAs inhibited cell proliferation and c-Myc expression, increased p27 expression caused G2/M phase cell cycle arrest in both YD-15 and Mc3 cells. HDAC7 silencing increased the sub-G1 population, Annexin V positive apoptotic cells and cleaved caspase3 levels. HDAC7 silencing induced an increase in autophagic markers, number of acidic vesicular organelles, and LC3B II levels, and decrease in p62 levels. HDAC7 siRNAs reduced the activation of ERK. HDAC7 knockdown resulted in grow inhibition through G2/M phase cell cycle arrest and induced both apoptosis and autophagy in MEC cells.
Conclusions
This study indicates that inhibition of HDAC7 might become a novel and effective therapeutic approach for treating to MEC.
This article is protected by copyright. All rights reserved.
http://ift.tt/2lpTOAn
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου